AbTx (Antibody for Therapy) is an expert in the development of an enzymatic bio-conjugation technology that will enable the design and development of homogeneous, stable, high-quality conjugated antibodies and antibody fragments. AbTx aims to develop a portfolio of drug candidates with a first indication in pancreatic cancer. To know more
